Vascular Targeted Radioimmunotherapy with 213Bi—An α-Particle Emitter-Reference-Cited by-同舟云学术

Vascular Targeted Radioimmunotherapy with 213Bi—An α-Particle Emitter

Published:1998-04 Issue:3 Volume:25 Page:241-246
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Kennel Stephen J,Mirzadeh Saed

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference29 articles.

1. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies;Blumenthal;Cancer Res.,1992

2. Boll R. A., Mirzadeh S., and Kennel S. J. (in press) Optimization of radiolabeling of immunoproteins with 213Bi. Radiochim. Acta.

3. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody;Borgström;Cancer Res.,1996

4. Synthesis of C-functionalized trans-cyclohexyldiethylenetriaminepenta-acetic acids for labeling of monoclonal antibodies with the bismuth-212 α particle emitter;Brechbiel;J. Chem. Soc. Perkin Trans.,1992

5. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels;Brooks;Cell,1994

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovation, Impact, and Strategic Importance of Alpha-Emitting Radionuclides;Journal of Medical Imaging and Radiation Sciences;2019-12

2. Microfluidics-based separation of actinium-225 from radium-225 for medical applications;Separation Science and Technology;2019-05-20

3. Finding Order in the Disordered Hydration Shell of Rapidly Exchanging Water Molecules around the Heaviest Alkali Cs+ and Fr+;The Journal of Physical Chemistry B;2018-11-27

4. Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated α-Radioimmunotherapy with 211At-MX35-F(ab′)2: Influence of Absorbed Tumor Dose and Effect on Long-Term Survival;Journal of Nuclear Medicine;2016-09-29

5. Availability of Alpha-Emitting Radioisotopes by Reactor and Accelerator Production and via Decay of Naturally Occurring Parents;Radiopharmaceuticals for Therapy;2016